⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12796565 | 0.79 | — | — | |
| SCHEMBL11328275 | 0.69 | — | — | |
| SCHEMBL7929054 | 0.69 | — | — | |
| SCHEMBL23529 | 0.68 | — | — | |
| SCHEMBL7921735 | 0.67 | — | — | |
| SCHEMBL10792468 | 0.67 | — | — | |
| SCHEMBL25368931 | 0.65 | — | — | |
| Ammonia Solution, Strong SCHEMBL17457516 | 0.65 | — | — | |
| SCHEMBL1937183 | 0.64 | — | — | |
| SCHEMBL9077720 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11833137-B2 | Substituted chromenones, IRE1 inhibitors, and methods of using same | THE WISTAR INSTITUTE (US) | 2023-12-05 | — | — | US | claimed |
| EP-2885279-A1 | CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | Janssen Pharmaceutica, N.V. (BE) | 2015-06-24 | — | — | EP | claimed |
| US-8853418-B2 | Cyclopentylpyrazoles as N-type calcium channel blockers | JANSSEN PHARMACEUTICA NV (BE) | 2014-10-07 | — | — | US | claimed |
| US-20140051660-A1 | CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-20 | — | — | US | claimed |
| WO-2014028801-A1 | CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | JANSSEN PHARMACEUTICA NV (BE) | 2014-02-20 | — | — | WO | claimed |
| US-8119563-B2 | N-substituted azacycles | FMC CORPORATION (US) | 2012-02-21 | — | — | US | claimed |
| US-20110245249-A1 | Heterocyclically Substituted Anilinopyrimidines | BAYER CROPSCIENCE AG (DE) | 2011-10-06 | — | — | US | claimed |
| EP-2331533-A1 | HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES | Bayer CropScience AG (DE) | 2011-06-15 | — | — | EP | claimed |
| US-20100286181-A1 | PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY | ASTRAZENECA AB (SE) | 2010-11-11 | — | — | US | claimed |
| WO-2010025850-A1 | HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | WO | claimed |
| EP-1673083-A2 | N-SUBSTITUTED AZACYCLES | FMC CORPORATION (US) | 2006-06-28 | — | — | EP | claimed |
| WO-2005103001-A1 | PHENYL ACETAMIDES | BAYER HEALTHCARE AG (DE) | 2005-11-03 | — | — | WO | claimed |
| EP-1572628-A1 | ISOPHTALIC ACID DERIVATIVES | Bayer HealthCare AG (DE) | 2005-09-14 | — | — | EP | claimed |
| WO-2005036961-A2 | N-SUBSTITUTED AZACYCLES | FMC CORPORATION (US) | 2005-04-28 | — | — | WO | claimed |
| WO-2004052839-A1 | ISOPHTALIC ACID DERIVATIVES | BAYER HEALTHCARE AG (DE) | 2004-06-24 | — | — | WO | claimed |
| EP-0142741-B1 | CYCLOHEXANE-1,3-DIONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COMBATING THE GROWTH OF UNDESIRABLE PLANTS | BASF Aktiengesellschaft (DE) | 1990-01-24 | — | — | EP | claimed |
| EP-0219091-B1 | PYRAN DERIVATIVES AND PROCESS FOR THEIR PREPARATION | BASF Aktiengesellschaft (DE) | 1989-04-26 | — | — | EP | claimed |
| EP-0219091-A2 | Pyran derivatives and process for their preparation | BASF Aktiengesellschaft (DE) | 1987-04-22 | — | — | EP | claimed |
| US-4654073-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1987-03-31 | — | — | US | claimed |
| EP-0142741-A2 | Cyclohexane-1,3-dione derivatives, process for their preparation and their use in combating the growth of undesirable plants | BASF Aktiengesellschaft (DE) | 1985-05-29 | — | — | EP | claimed |